 |
PDBsum entry 2uxn
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Tunnel analysis for: 2uxn calculated with MOLE 2.0
|
PDB id
|
|
|
|
2uxn
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Tunnels calculated on whole structure |
 |
Tunnels calculated excluding ligands
|
|
|
 |
 |
 |
 |
 |
|
 |
|
|
|
 |
 |
|
 |
|
|
|
 |
3 tunnels,
coloured by tunnel radius |
 |
15 tunnels,
coloured by
tunnel radius
|
15 tunnels,
coloured as in list below
|
|
|
 |
 |
 |
Tunnels are interior spaces connected with the protein surrounding. Only channels longer than 15 Å are shown. |
|
|
 |
|
|
|
 |
Free R
|
 |
|
|
|
|
 |
Length
|
 |
|
|
|
|
 |
HPathy
|
 |
|
|
|
|
 |
HPhob
|
 |
|
|
|
|
 |
Polar
|
 |
|
|
|
|
 |
Rel Mut
|
 |
|
|
|
|
 |
Residue..type
|
 |
|
|
|
|
 |
Ligands
|
 |
|
|
|
|
|
 |
Radius |
 |
1 |
 |
1.78 |
2.06 |
26.1 |
-0.72 |
-0.18 |
10.1 |
78 |
 |
3 |
1 |
2 |
4 |
1 |
2 |
0 |
 |
FDA 900 A
|
 |
 |
2 |
 |
1.51 |
1.51 |
26.8 |
-0.87 |
-0.23 |
11.6 |
81 |
4 |
1 |
2 |
4 |
1 |
2 |
0 |
FDA 900 A
|
 |
3 |
 |
1.79 |
2.05 |
27.8 |
-0.52 |
-0.08 |
10.4 |
79 |
3 |
1 |
1 |
7 |
1 |
2 |
0 |
FDA 900 A
|
 |
4 |
 |
1.39 |
2.30 |
34.8 |
-0.50 |
-0.28 |
11.8 |
93 |
3 |
1 |
0 |
8 |
1 |
0 |
0 |
FDA 900 A LYP 4 E
|
 |
5 |
 |
1.42 |
1.42 |
34.9 |
-0.38 |
-0.27 |
10.1 |
93 |
2 |
1 |
0 |
7 |
1 |
0 |
0 |
FDA 900 A LYP 4 E
|
 |
6 |
 |
1.33 |
2.39 |
38.6 |
-1.13 |
-0.44 |
13.7 |
93 |
3 |
2 |
1 |
5 |
1 |
0 |
0 |
FDA 900 A LYP 4 E
|
 |
7 |
 |
1.40 |
1.40 |
38.6 |
-1.03 |
-0.43 |
12.2 |
93 |
2 |
2 |
1 |
4 |
1 |
0 |
0 |
FDA 900 A LYP 4 E
|
 |
8 |
 |
1.36 |
1.34 |
40.7 |
-1.17 |
-0.45 |
14.4 |
93 |
4 |
2 |
1 |
5 |
1 |
0 |
0 |
FDA 900 A LYP 4 E
|
 |
9 |
 |
1.42 |
1.40 |
40.8 |
-1.09 |
-0.45 |
13.2 |
94 |
3 |
1 |
1 |
4 |
1 |
0 |
0 |
FDA 900 A LYP 4 E
|
 |
10 |
 |
1.25 |
1.51 |
41.7 |
0.07 |
0.11 |
8.8 |
80 |
2 |
1 |
2 |
8 |
3 |
0 |
1 |
FDA 900 A LYP 4 E
|
 |
11 |
 |
1.24 |
2.26 |
45.4 |
-0.45 |
-0.02 |
9.9 |
79 |
2 |
1 |
3 |
5 |
3 |
0 |
1 |
FDA 900 A LYP 4 E
|
 |
12 |
 |
1.23 |
1.50 |
47.6 |
-0.63 |
-0.09 |
11.8 |
79 |
3 |
2 |
3 |
5 |
3 |
0 |
1 |
FDA 900 A LYP 4 E
|
 |
13 |
 |
1.23 |
3.17 |
30.0 |
0.54 |
0.29 |
10.4 |
78 |
2 |
0 |
2 |
10 |
2 |
1 |
0 |
|
 |
14 |
 |
1.23 |
1.74 |
16.4 |
0.68 |
0.13 |
2.1 |
73 |
0 |
0 |
1 |
4 |
2 |
1 |
0 |
|
 |
15 |
 |
1.48 |
3.96 |
21.6 |
-2.35 |
-0.16 |
24.9 |
69 |
2 |
2 |
0 |
0 |
1 |
1 |
0 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Residue-type_colouring |
 |
|
 |
|
Positive
|
Negative
|
Neutral
|
Aliphatic
|
Aromatic
|
Pro & Gly
|
Cysteine
|
|
H,K,R
|
D,E
|
S,T,N,Q
|
A,V,L,I,M
|
F,Y,W
|
P,G
|
C
|
|
|
 |